Optimizing the Devlopment of Antipsychotic Drugs [Hardcover]

John J. Sramek (Author), Neal R. Cutler (Author), Neil M. Kurtz (Author), Michael F. Murphy (Author), Angelico Carta (Author)

Book Description

ISBN-10: 0471970115 | ISBN-13: 978-0471970118 | Publication Date: March 11, 1998 | Edition: 1

The interest in developing novel antipsychotics is especially keen at this time and this book presents the latest information in that development. Numerous compounds are in the preclinical and clinical pipeline. The pharmaceutical industry, as well as psychiatrists, clinicians, mental health professionals and anyone else interested in the design and conduct of clinical trials of schizophrenia, are waiting for these research results. Revealing recommendations for developing antipsychotic compounds based on the extensive experience of the authors, this work will provide long-awaited information on a previously unexplored area.

Editorial Reviews

From the Publisher

The interest in developing novel anxiolytics is especially keen at this time and this book looks at the latest information in that development. Numerous compounds are in the preclinical pipeline and the pharmaceutical industry, as well as anyone interested in the design and conduct of schizophrenia clinical trials, are waiting for these research results. Revealing recommendations for developing anxiolytic compounds based on the extensive experience of the authors, this work will provide long-awaited information on a so far uncovered new area.

Product Details

• Hardcover: 216 pages
• Publisher: John Wiley & Sons; 1 edition (March 11, 1998)
• Language: English
• ISBN-10: 0471970115
• ISBN-13: 978-0471970118
• Product Dimensions: 9.5 x 6.2 x 0.7 inches
• Shipping Weight: 15.4 ounces
• Amazon Best Sellers Rank: #4,474,578 in Books (See Top 100 in Books)